Pursuant to Regulation 33(3)(d) read with Regulation 47(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed about submission of the Certified True Copies of publication of Standalone Un-Audited Financial Results for the Quarter ended 31st December, 2018, approved at the meeting of the Board of Directors of the company held on 13th February, 2019 at the registered office of the company. Further, the publication was made in one English and Hindi Newspaper of Business Standard respectively.
The above information is a part of company’s filings submitted to BSE.
